Walnuts and omega-3 to help weight loss before prostate surgery
Part of Cancer, Kidney & urinary clinical trials.
This Phase 2 study tests whether adding walnuts (and related nutrients like omega-3s) can help with weight loss and energy in people with prostate cancer who are planning prostate removal surgery. It aims to see if diet changes improve how you feel and manage weight before and around treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed prostate cancer (prostate adenocarcinoma)
- Your biopsy shows Grade Group 2 or higher (Gleason 7 or more)
- You plan to have prostate removal surgery (RP)
- You can and are willing to follow the study diet, which may include 2 ounces of walnuts daily
- You must not be allergic to nuts
- You understand English well enough to consent and follow instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medically designed Mediterranean diet can help men before prostate cancer surgery. You would eat special foods and be monitored closely to see how the diet affects your health and recovery.
This study tests if taking tirzepatide (a weight loss medicine) before prostate removal surgery is safe and helpful for overweight men with intermediate-risk prostate cancer. It aims to see if losing weight can improve surgery outcomes.
This Phase 3 trial studies whether taking curcumin (a supplement made from turmeric) after radical prostatectomy can help keep prostate cancer from coming back. Participants are men with low-risk, surgery-only disease and undetectable PSA, and the study checks recurrence-free survival over time.
This study tests whether a personalized exercise and support program before and after robot-assisted prostate cancer surgery helps men recover better function and quality of life. You'll work with a team to prepare your body before surgery and rebuild strength afterward.
This trial tests a new drug (BMS-986365) combined with another hormone therapy (degarelix) before radical prostatectomy for high-risk prostate cancer. The goal is to see if this combination helps lower cancer activity before surgery.
This Phase 2 trial studies whether pembrolizumab plus a hormone “androgen axis” blocker taken before prostate surgery can improve outcomes for people with high-risk, non-metastatic prostate cancer. It’s designed for patients who are planning prostate removal with an extended lymph node dissection.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.